Clinical trial
Immunosuppression in Patients Undergoing Liver Transplantation for…
NCT00355862 · University of Regensburg, Other · Completed
Key facts
| NCT number | NCT00355862 |
|---|---|
| Title | Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma |
| Official title | A Prospective Randomised, Open-labeled, Trial Comparing Sirolimus-Containing Versus mTOR-Inhibitor-Free Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma |
| Lead sponsor | University of Regensburg, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatocellular Carcinoma |
| Intervention type | Drug |
| Interventions | CNI, MMF, Steroids, Aza etc. (mTOR inhibitor free), Sirolimus |
| Enrollment | 525 |
| Start date | Jan 1, 2006 |
| Primary completion | Apr 1, 2009 |
| Completion | May 1, 2014 |
| First posted | Jul 25, 2006 |
| Last update posted | Jul 30, 2014 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: